Tvardi Therapeutics Inc. (TVRD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tvardi Therapeutics Inc.

    NASDAQ: TVRD · Real-Time Price · USD
    40.23
    2.86 (7.65%)
    At close: Oct 03, 2025, 3:59 PM
    40.55
    0.80%
    After-hours: Oct 03, 2025, 04:21 PM EDT

    Tvardi Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
    Revenue
    		 6.58M 7.57M 7.14M 8.69M 11M 10.01M 7.87M 4.87M
    Cost of Revenue
    		 120K 150K 770K 1.46M 3M 2.93M 2.31M 1.62M
    Gross Profit
    		 6.42M 7.38M 6.33M 7.23M 7.99M 7.08M 5.56M 3.25M
    Operating Income
    		 -23.56M -30.9M -58.18M -56.84M -79.44M -63.23M -33.56M -28.9M
    Interest Income
    		 1.56M 1.88M 2.83M 2.72M 2.82M 2.13M 1.18M 866K
    Pretax Income
    		 -21.29M -45.48M -71.27M -67.54M -83.09M -63.08M -32.38M -28.03M
    Net Income
    		 -20.89M -45.08M -70.87M -67.54M -83.09M -63.08M -32.38M -28.03M
    Selling & General & Admin
    		 20.93M 24.24M 26.39M 20.24M 20.56M 14.19M 7.41M 6.72M
    Research & Development
    		 7.66M 11.12M 32.77M 36.58M 60.64M 51.37M 29.41M 25.42M
    Other Expenses
    		 1.43M 2.96M 5.39M 4.94M 3.92M 2.43M n/a n/a
    Operating Expenses
    		 30.02M 38.32M 64.55M 61.76M 85.12M 67.99M 36.81M 32.15M
    Interest Expense
    		 7.45M 9.36M 8.47M 5.85M 3.89M 1.98M n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 30.14M 38.47M 65.32M 62.53M 87.43M 70.23M 38.43M 33.76M
    Income Tax Expense
    		 -398K -398K -398K n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 8.25M 9.36M 1.52M 1.52M 1.52M 9.36M 9.36M 1.51M
    Shares Outstanding (Diluted)
    		 8.46M 9.36M 1.52M 1.52M 1.52M 9.36M 9.36M 1.51M
    EPS (Basic)
    		 -13.24 -26.92 -29.68 -25.1 -35.52 -22.35 -19.07 -18.61
    EPS (Diluted)
    		 -14.75 -26.92 -29.68 -25.1 -35.52 -22.35 -19.07 -18.61
    EBITDA
    		 -26.76M -35.97M -62.6M -60.47M -77.53M -59.51M -30.83M -27.51M
    EBIT
    		 -26.88M -36.12M -62.79M -60.68M -78.2M -60.09M -31.38M -28.03M
    Depreciation & Amortization
    		 120K 150K 192K 216K 664K 587K 545K 521K

    Add to Watchlist